Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01254162 · ClinicalTrials.gov registry record · Phase 2
Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers
A Phase 2 study of Oily Skin and Seborrhea, sponsored by Mimetica Pty Limited.
- Completed
- Registry status
- Phase 2
- Development phase
- 135
- Enrollment target
- 1
- Study location
NCT01254162: Completed Phase 2 study of Oily Skin and Seborrhea, sponsored by Mimetica Pty Limited.
NCT01254162 is a Phase 2 study of Oily Skin and Seborrhea that has completed, run by Mimetica Pty Limited. The registered enrollment target is 135 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01254162, a Phase 2 study of Oily Skin and Seborrhea, has completed, sponsored by Mimetica Pty Limited.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 135 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the potential of topically applied 0.75% (w/w) MTC896 Gel to reduce sebum production on the forehead of healthy male volunteers.
Interventions
- DRUG MTC896 Gel
Study Locations (1)
New Jersey
- TKL Research, Inc - Paramus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
What the finished NCT01254162 record still lists
NCT01254162 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 2 conditions, with Oily Skin appearing as the primary indexed condition, and to 1 intervention - of which MTC896 Gel is the first listed.
NCT01254162 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT01254162 about?
NCT01254162 is a clinical study titled "Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers". To determine the potential of topically applied 0.75% (w/w) MTC896 Gel to reduce sebum production on the forehead of healthy male volunteers.
What is the current status of trial NCT01254162?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 135 participants. The study started on 2010-07. Estimated completion is 2011-08.
What conditions does trial NCT01254162 study?
This clinical trial studies the following conditions: Oily Skin, Seborrhea.
What interventions are being tested in trial NCT01254162?
The interventions under investigation include: MTC896 Gel (DRUG).
Who is sponsoring clinical trial NCT01254162?
This trial is sponsored by Mimetica Pty Limited, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01254162 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01254162's enrollment target sits among peer trials
135 532nd of 2000 higher than 1,464 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia